Immunic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEODaniel Vitt
CEODaniel Vitt
Employees91
Employees91
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2003
Founded2003
Employees91
Employees91
IMUX Key Statistics
Market cap70.63M
Market cap70.63M
Price-Earnings ratio-0.62
Price-Earnings ratio-0.62
Dividend yield—
Dividend yield—
Average volume1.63M
Average volume1.63M
High today$0.595
High today$0.595
Low today$0.5372
Low today$0.5372
Open price$0.556
Open price$0.556
Volume1.39M
Volume1.39M
52 Week high$1.39
52 Week high$1.39
52 Week low$0.5062
52 Week low$0.5062
Stock Snapshot
With a market cap of 70.63M, Immunic(IMUX) trades at $0.60. The stock has a price-to-earnings ratio of -0.62.
During the trading session on 2026-01-02, Immunic(IMUX) shares reached a daily high of $0.60 and a low of $0.54. At a current price of $0.60, the stock is +10.8% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 1.39M, compared to an average daily volume of 1.63M.
Over the past 52 weeks, Immunic(IMUX) stock has traded between a high of $1.39 and a low of $0.51.
Over the past 52 weeks, Immunic(IMUX) stock has traded between a high of $1.39 and a low of $0.51.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IMUX. This list is generated using Robinhood data, and it’s not a recommendation.